Article
Host–pathogen interaction inCandida glabratainfection: current knowledge and implications for antifungal therapy
15 Jul 2020
Abstract excerpt
Introduction The opportunistic fungal pathogen Candida glabrata poses a clinical challenge in the successful treatment of invasive Candida infections, owing to its low inherent susceptibility toward azole antifungals and the recent acquisition of coresistance toward azole and echinocandin drugs. Compared to other prevalent Candida bloodstream pathogens, C. glabrata neither exhibits secreted proteolytic activity...
Topics
Join the communities discussing this publication.